SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LNSR

LENSAR, Inc. (NASDAQ:LNSR)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$5.00+$0.30 (+6.38%)
 
Market cap
$61.5M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 2, 2020
Website
Market Cap$61.47M-50.5%
Revenue (ttm)$60.08M+1.6%
Net Income$33.69M+165.4%
EPS$2.74+90.9%
Shares Out12.29M
PE Ratio1.82
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume46,886
Open$4.71
Previous Close$4.70
Day's Range$4.71 - $5.08
52-Week Range$4.30 - $12.94
Beta0.95
AnalystsBuy
Price Target$11.00(+120.00%)
Earnings DateMar 9, 2027
+6.38% (1D)
No price history available.

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Address
2800 Discovery Drive, Orlando, FL, 32826, US
Market Cap
61 million
Employees
150
Industrial Classification
Medical - Devices

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $11.00 (+120.0%)

1 firm rating LNSR in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Strong
From LNSR’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+6.38%
5 Days
-9.26%
1 Month
-18.17%
6 Months
-14.24%
1 Year
-50.54%

$LNSR stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in LNSR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by LNSR's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

LNSR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

LNSR Revenue by Segment or Geography

LNSR's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New LNSR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to LNSR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in LNSR

VTIVanguard Morningstar Total Stock Market ETF$1.82M
VXFVanguard Extended Market ETF$754.50K
DFASDimensional - US Small Cap ETF$183.40K
IWCiShares Micro-Cap ETF$135.20K
DFMCU.S. Micro Cap Portfolio ETF$64.02K
DFATDimensional - US Targeted Value ETF$33.92K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from LNSR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.